advanced infusion solutions lawsuit

Repair Your Reputation The Right Way Corporate Advocacy Program And "[b]y submitting the misrepresented claims[,] AIS falsely represented to [BCBS and AHS] that it provided direct per diem infusion services," which was "inconsistent with [BCBS and AHS's] justified expectations under the Agreement." Those the Court does not address would not have changed the outcome. In-Office Appointments. 623 Highland Colony Parkway, Suite 100. [Previously dismissed case: No] [Possible companion case(s): None] (Moody, Nolan) (Entered: 01/11/2021). 2:19-CV-12369 | 2019-08-09, U.S. District Courts | Other | Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions, 2:21-cv-10076 Brought to you by the RECAP Initiative and Free Law Project, a non-profit dedicated to creating high quality open legal information. The medication in the pump lasts between a week and several months without requiring the patient to see a healthcare provider. Subscribe to Justia's Free Newsletters featuring summaries of federal and state court opinions. Jul. We have the following opinions for this case: This docket was last retrieved on October 25, 2021. Listed below are those cases in which this Featured Case is cited. Redaction Request due 7/27/2021. advanced infusion solutions lawsuit. Nora Apothecary and Alternative Therapies, Inc. Advanced Infusion Solutions (AIS) Fabricacin de productos farmacuticos Ridgeland, Mississippi MMM Holdings LLC . (LSau) (Entered: 04/06/2021), Docket(#10) NOTICE of Appearance by Paul Anthony Werner, III on behalf of Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions. Namely, AIS contends they fail to establish the representation, materiality, and intent elements of the claim and to allege the "who, what, when, where, and how." But they disagree as to whether AIS breached it. (877) 443-4006. Pharmacy, Inc., Midland, TX- 503A Facility, Drug Crafters, L.P., Frisco, TX- 503A Facility, Drug Depot Inc. (dba APS Pharmacy), Palm Harbor, FL- 503A Facility, Drugs are Us, Inc. (dba Hopewell Pharmacy), Hopewell, NJ- 503A Facility, Duren's Health Mart Pharmacy, Waynesboro, TN- 503A Facility - Ceased Compounding Operations, Dynalabs LLC, Saint Louis, MO- 503A Facility, Eagle New York, Garfield, NJ- 503A Facility, Eagle Pharmacy, Inc., Hoover, AL- 503B Facility, East Marietta Drug Company, Marietta, GA- 503A Facility, Eastern Pharmacy, Inc., Ocala, FL- 503A Facility, Eastern States Compounding Pharmacy,(see Northern New England Compounding Pharmacy), Littleton, NH- 503A Facility, Edge Pharmacy Services, LLC, Colchester, VT- 503B Facility, EHT Pharmacy LLC, (dba Curexa), Egg Harbor Township, NJ- 503A Facility, Elkhart Pharmacy, Elkhart, TX- 503A Facility - Out of business, Empower Clinic Services, LLC, Houston, TX- 503B Facility, Enclara Pharmacia Inc., Sharon Hill, PA- 503A Facility - Ceased sterile compounding, Essential Pharmacy Compounding, Omaha, NE- 503A Facility, Essential Wellness Pharma, (see Kalman Health & Wellness Inc.), Peoria, IL- 503A Facility, Everwell Specialty Pharmacy, Pensacola, FL (see Pensacola Apothecary Inc.)- 503A Facility, Exela Pharma Sciences, LLC, Lenoir, NC- 503B Facility, Expert Compounding Pharmacy, Lake Balboa, CA - 503A Facility, Fagron Compounding Services LLC (dba Fagron Sterile Services), Wichita, KS- 503B Facility, Fairview Compounding Pharmacy, Minneapolis, MN- 503A Facility, Fallon Wellness Pharmacy, LLC, Latham, NY- 503A Facility, Family Pharmacy of Statesville, Inc., Statesville, NC- 503A Facility, Far Hills Pharmacy, (see Pharmaview, Inc.), Bedminster, NJ- 503A Facility, Farmacia Le Salud Inc., Caguas, PR- 503A Facility, Farmakeio Outsourcing LLC, Southlake, TX- 503B Facility, Farmville Discount Drug, Inc., (dba Best Value Drug), Farmville, NC- 503A Facility - Out of business, FH Investments Inc., (dba Asteria Health), Birmingham, AL- 503B Facility, First Call IV Pharmacy, LLC, Kenner, LA- 503A Facility, First Pharma Associates LLC (dba Riverpoint Pharmacy), Spokane, WA- 503A Facility, First Royal Care Co. LLC, (dba Red Mountain Compounding Pharmacy), Mesa, AZ- 503A Facility, Flourish Integrative Pharmacy, LLC, Oklahoma City, OK- 503A Facility, Foothills Professional Pharmacy, Ltd., Phoenix, AZ- 503A Facility, Foundation Care LLC, Earth City, MO- 503A Facility, Franck's Compounding Lab (see Franck's Lab, Inc.), Ocala, FL- 503A Facility - Out of business, Franck's Lab, Inc.(dba Franck's Compounding Lab), Ocala, FL- 503A Facility - Out of business, Franck's Lab, Inc.(dba Trinity Care Solutions), Ocala, FL- 503A Facility - Out of business, Freedom Fertility Pharmacy, (see Lynnfield Drug, Inc.), Byfield, MA- 503A Facility, Freedom Pharmacy,(see HHCS Pharmacy, Inc.), Orlando, FL- 503A Facility, Fresenius Kabi Compounding, LLC, Canton, MA- 503B Facility, Front Door Pharmacy, LLC, (dba Pure Pharmacy), Houston, TX- 503A Facility, Front Range Laboratories, Incorporated, Loveland, CO- 503A Facility, Fusion IV Pharmaceuticals Inc. (dba Axia Pharmaceuticals), Los Angeles, CA- 503A Facility - De-registered as an Outsourcing Facility, FVS Holdings, Inc. (dba Green Valley Drugs), Henderson, NV- 503A Facility - Out of business, Garda Rx LLC., Apollo, PA- 503A Facility, Geneva Woods Pharmacy, Anchorage, AK- 503A Facility, Gipsco Investment Corp. (dba Lee Silsby Compounding Pharmacy), Cleveland Heights, OH- 503A Facility, Glades Drugs, Pahokee, FL- 503A Facility, Good Day Pharmacy, (see Professional Pharmacy Services, Inc.), Loveland, CO- 503A Facility, Good Health Inc., (dba Premier Pharmacy Services), Baldwin Park, CA- 503A Facility, Grandpa's Compounding Pharmacy, Inc. Placerville, CA- 503A Facility - Out of business, Green Hills Health and Wellness Pharmacy, Inc. (dba Health and Wellness Compounding Pharmacy),Nashville, TN- 503A Facility, Greenpark Compounding Pharmacy, (see Prescription Labs, Inc.), Houston, TX- 503A Facility, Green Valley Drugs,(see FVS Holdings, Inc.), Henderson, NV- 503A Facility, Guardian Pharmacy Services, Dallas, TX- 503A Facility - Out of business, Hallandale Pharmacy, (see Pharmcore Inc.), Hallandale, FL- 503A Facility, Hallettsville Pharmacy, LLC, Hallettsville, TX- 503A Facility, Hartley Medical Center Pharmacy, Inc., Long Beach, CA- 503A Facility, Hawaii Health Systems Corporation, (dba Kona Community Hospital Pharmacy), Kealakekua, HI- 503A Facility, Hazle Compounding, LLC, Hazelton, PA, 503A, Healix Infusion Therapy, Inc., Sugar Land, TX- 503A Facility - De-registered as an Outsourcing Facility, Health and Wellness Compounding Pharmacy,(see Green Hills Health and Wellness Pharmacy, Inc.), Nashville, TN- 503A Facility, Health Dimensions, Inc., Farmington Hills, MI- 503A Facility, Health Innovations Pharmacy, Inc., Southern Pines, NC- 503A Facility, The Healthy Choice Apothecary (see Jacobs Pills Inc.), Elmsford, NY- 503A Facility, Healthy Choice Compounding LLC, Elmsford, NY 483- 503A Facility, Heartland Home Infusions, Inc. (dba HHI Infusion Services), Burr Ridge, IL- 503A Facility, Heartland I.V. Signed by District Judge Denise Page Hood. 3:11 . County of 1st Plaintiff: Wayne - County Where Action Arose: Wayne - County of 1st Defendant: Out of State. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. In Mississippi, "[a] breach-of-contract case has two elements: (1) the existence of a valid and binding contract; and (2) a showing that the defendant has broken, or breached it." Commc'ns, Inc. v. Banks,90 So.3d 1221, 1224 (Miss. vitamine pentru pofta de mancare si ingrasare copii. Last updated on September 30th, 2020 at 11:43 am The closure of Advanced Pain Management ambulatory surgical centers and. I must pay the remaining amount. Id. Receipt No: AMIEDC-8266539 - Fee: $ 402. D/B/A ADVANCED INFUSION CARE Court:United States District Court, Eastern District of Louisiana Date published: Jul 30, 2021 CitationsCopy Citation Civil Action 21-774 (E.D. Referral Letter to the Arizona Board of Pharmacy Issued 03/30/2015, Referral Letter to the Virginia Board of Pharmacy Issued 10/27/2016, Referral Letter to Virginia Board of Pharmacy Issued 08/13/2013, Referral Letter to the California State Board of Pharmacy Issued 09/29/2020, Referral Letter to the California State Board of Pharmacy Issued 12/27/2020, Referral Letter to the California State Board of Pharmacy Issued 07/08/2019, Referral Letter to the Alabama State Board of Pharmacy Issued 08/14/17, State Referral Letter to the Washington State Department of Health Issued 04/18/2018, Referral Letter to New York State Board of Pharmacy Issued 04/21/2015, Referral Letter to the California State Board of Pharmacy Issued 06/23/2015, Referral Letter to the New Jersey State Board of Pharmacy Issued 01/03/2017, Referral Letter to the Texas State Board of Pharmacy Issued 09/21/2020, Referral Letter to the Texas State Board of Pharmacy Issued 04/24/2019, Referral Letter to the South Carolina Department of Labor and Licensing- Board of Pharmacy Issued 02/15/2017, Referral to the Florida State Board of Pharmacy Issued 07/28/2017, Referral Letter to the Illinois State Board of Pharmacy Issued 05/05/2020, Referral Letter to the Tennessee Board of Pharmacy Issued 02/06/2019, Referral Letter to the New York State Board of Pharmacy Issued 01/09/2017, Referral Letter to Washington State Board of Pharmacy Issued 08/01/2017, Referral Letter to Utah State Board of Pharmacy Issued 02/20/2014, Referral Letter to the Arizona State Board of Pharmacy dated 02/06/2020, Referral Letter to the Minnesota State Board of Pharmacy Issued 10/22/2019, Referral Letter to the Alabama State Board of Pharmacy Issued 04/15/2015, Referral Letter to the Illinois State Board of Pharmacy Issued 04/03/2019, Referral to the New York City Department of Health and Mental Hygiene Issued 08/08/2017, Referral Letter to the Connecticut Commission of Pharmacy Issued 03/25/2015, FDA Statement: FDA Alerts Pharmacies to Concerns with Testing Conducted by Front Range Laboratories, See FDA's Enforcement Report to Search Recalls, Including Compounded Drug Products, Inspections, Recalls, and Other Actions with Respect to Firms that Engage in Animal Drug Compounding. P. 9(b). Learn more about our pharmacies: AIS Healthcare Targeted Drug Delivery Nursing that exceeds expectations $52,000 - $65,999 10% of jobs $66,000 - $79,999 13% of jobs The average salary is $93,518 a year $80,000 - $93,999 13% of jobs $94,000 - $107,999 12% of jobs A more recent docket listing The site is secure. Mississippi, Northern Division.https://leagle.com/images/logo.png. [21-30534] (Imad Sayed Matini ) [Entered: 09/13/2021 03:45 PM], APPEARANCE FORM received from Mr. Paul Anthony Werner, III for Bond Pharmacy, Incorporated for the court's review. Second Amend. Sufficient Mtn/Resp/Reply due on 10/26/2021 for Appellant Randy Denning. Fed. Balloon Sleeve Big silhouette Over Shirt/ 21-30534 Decided: September 30, 2022 Before Stewart, Clement, and Elrod, Circuit Judges. La. 2022 Beckoning-cat.com. The .gov means its official.Federal government websites often end in .gov or .mil. [21-30534] (Roberta Louise Burns ) [Entered: 09/14/2021 10:55 AM], APPEARANCE FORM for the court's review. 2:23-CV-00124 | 2023-01-31, U.S. District Courts | Property | We bill your health insurance provider directly for all medication and services, and work directly with the insurer to facilitate your reimbursement. Id. Our inspiration came from the infusion experiences of our close family: Annette's brother and Lucien's father. P. 8(d)(2). Document is insufficient for the following reasons: Motion does not contain a Certificate of Compliance. Id. Rule 9(b) requires a party to plead with particularity the circumstances constituting fraud. [21-30534] (SEP) [Entered: 09/15/2021 10:20 AM], APPEARANCE FORM FILED by Attorney Roberta Louise Burns for Appellant Randy Denning in 21-30534. (dba The Wellness Pharmacy), Winchester, VA- 503A Facility, Kalman Health & Wellness, Inc. (dba Essential Wellness Pharma), Peoria, IL- 503A Facility, Kelley-Ross Compounding Pharmacy, Seattle, WA- 503A Facility, Key Compounding Pharmacy (see Puget Sound Drug Corporation), Federal Way, WA- 503A Facility, Keystone Pharmacy, Grand Rapids, MI- 503A Facility, Keystone Rx LLC, Bensalem, PA- 503A Facility, Kings Park Slope, Inc., Brooklyn, NY- 503A Facility - De-registered as an Outsourcing Facility, Kohana Pharmacy and Center for Regenerative Medicine Inc., San Luis Obispo, CA- 503A Facility, Kohll's Compounding, Omaha, NE- 503A Facility, Kona Community Hospital Pharmacy, (see Hawaii Health Systems Corporation), Kealakekua, HI- 503A Facility, KRS Global Biotechnology, Inc. Boca Raton, FL- 503B Facility, Ladd Family Pharmacy LLC, Boise, ID- 503A Facility, Lato Drug Company, Inc. (dba Post Haste Pharmacy), Hollywood, FL- 503A Facility, La Vita Compounding Pharmacy, LLC, San Diego, CA- 503A Facility, Lee and Company (dba Lee Pharmacy, Inc.), Fort Smith, AR- 503A Facility - Out of business, Lee Pharmacy, Inc.(see Lee and Company), Fort Smith, AR- 503A Facility, LeeSar, Inc., Fort Myers, FL- 503B Facility, Lee Silsby Compounding Pharmacy, (see Gipsco Investment Corp.), Cleveland Heights, OH- 503A Facility, Leiter's Cambrian Park Drugs, Inc., (dbaLeiter's Compounding Pharmacy), 1700 Park Avenue, San Jose, CA- 503A Facility - Out of business, Leiter's Compounding, 17 Great Oaks Blvd., San Jose, CA- 503A Facility, Leiter's Compounding Pharmacy,(see Leiter's Cambrian Park Drugs, Inc.), San Jose, CA- 503A Facility, Leiter's Health, (see Denver Solutions, LLC), Englewood, CO- 503A Facility, Liberty Drug and Surgical, Chatham, NJ- 503A Facility, Life Science Pharmacy, Inc., Harriman, NY- 503A Facility, Lifetime Value Pharmacy III Inc., Santa Ana, CA- 503A Facility, Lincare, Inc. (dba United Medical Home Infusion), Little Rock, AR- 503A Facility, Lloyd Central Compounding Pharmacy, (see Portland Compounding Pharmacy, LLC), Portland, OR- 503A Facility, Loop Pharmacy & Home Medical, Saint Albans, WV- 503A Facility, Louisville Pharmacy (see Spoonamore Drug Co., Inc.), Louisville, KY- 503A Facility, Lowlite Investments, Inc. (dba Olympia Pharmacy), Orlando, FL- 503A Facility, Lowlyn Pharmacies, Inc. (dba Red Cross Drug), Blanchard, OK- 503A Facility, Lynnfield Drug, Inc. (dba Freedom Fertility Pharmacy), Byfield, MA- 503A Facility, Lynn Oaks Compounding Pharmacy, Thousand Oaks, CA - 503A Facility, M Drug, LLC, (dba Northern Light Pharmacy), Bangor, ME- 503A Facility, Maag Prescription Center LLC, Pocatello, ID- 503A Facility, Madison Drugs (see Service First Pharmacies, Inc.), Huntsville, AL- 503A Facility, Magellan Rx Pharmacy LLC, Astoria, NY- 503A Facility, Maimonides Medical Center-Pharmacy, Brooklyn, NY- 503A Facility, Main Street Family Pharmacy, Newbern, TN- 503A Facility - Out of business, Maitland Labs of Central Florida, Orlando, FL- 503A Facility - Out of business, Malley's Compounding Pharmacy, (see Columbia River Pharmacy, LLC), Richland, WA- 503A Facility, Malanda, Inc., (dba Mandell's Clinical Pharmacy), Somerset, NJ- 503A Facility, Maplerose Enterprises, LLC (dba Pencol Pharmacy), Denver, CO- 503A Facility, Mark Drugs Pharmacy, (see Snyder Mark Drugs Roselle, Inc.), Roselle, IL- 503A Facility, Martin Avenue Pharmacy, Inc., Naperville, IL- 503A Facility, Maryland Specialty and Compounding, LLC dba Professional Arts Pharmacy, Baltimore, MD- 503A Facility - Ceased sterile compounding, MasterPharm LLC. 47. Ferrara v. Walters,919 So.2d 876, 886 (Miss. Id. Release of Transcript Restriction set for 10/4/2021. A more recent docket listing Based on the record as it presently . Access this case on the Michigan Eastern District Court's Electronic Court Filings (ECF) System. 1992) (citation omitted). These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia. This Court dismissed the ERISA claims. AIS, according to BCBS and AHS, only compounded and shipped the pump medication to treating providers without filling/refilling the pumps or providing ongoing services, and therefore breached the Agreement. "Threadbare recitals of the elements of a cause of action, supported by mere conclusory statements" do not satisfy a plaintiff's pleading burden. AIS argues that BCBS and AHS merely provide a "formulaic recitation of the elements." If no request is filed, the transcript may be made remotely electronically available to the public without redaction after 90 days. [rux-a2015w-lpg] [rux-a2015w-lpg] 20 bl 15a iii rux-a2015w Doe v. MySpace, Inc.,528 F.3d 413, 418 (5th Cir. Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions Plaintiff: Blue Cross Blue Shield of Michigan: Defendant: Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions: Case Number: 2:2021cv10076: Filed: January 11, 2021: Court: US District Court for the Eastern District of Michigan: Presiding Judge: Because the Counterclaim provides enough particularity to provide AIS with notice, the Court denies AIS's motion on this claim. United States District Court, S.D. No. (Attachments: #1 Index of Exhibits, #2 Exhibit 1 - BCBS Agreement, #3 Exhibit 2 - Letter from BCBS, #4 Exhibit 3 - Letter from Sheppard Mullin) (Winsten, I.) See AIS's Memo. P. C., New York, NY- 503A Facility, Wingate's Pharmacy and Compounding (see Anderson Holdings Inc.), Nashua, NH- 503A Facility, Wise Pharmacy, (see Joe Wise Pharmacy, Inc.), Littleton, CO- 503A Facility, Woodland Hills Compounding Pharmacy, (see Algunas, Inc.), Woodland Hills, CA- 503A Facility, Wood's Pharmacy, Inc., (dba The Medicine Shoppe), Boones Mill, VA- 503A Facility, Yeung Business Solutions, LLC, (dba Reliant Pharmacy), Southbury, CT- 503A Facility, Zion Clinical Pharmacy, (see Pharmacy Doctors Enterprises), Hallandale Beach, FL- 503A Facility, Zions RX Formulations Services, (see Rx Formulations), Mesa, AZ- 503A Facility, Analytical Research Laboratories, (see ARL Biopharma, Inc.), Oklahoma City, OK, ARL Biopharma, Inc., (dba Analytical Research Laboratories), Oklahoma City, OK, Front Range Laboratories, Inc., Loveland, CO, Medisca Inc., Saint-Laurent, Quebec, Canada, and Plattsburgh, NY, Professional Compounding Centers of America, dba PCCA, Houston, TX, Sichuan Friendly Pharmaceutical Co., Limited, China, Taizhou Xinyou Pharmaceutical & Chemical Co., Limited, Taizhou City, Zhejiang Province, China, An official website of the United States government, : Text Size:thredup ambassador program how to dress more masculine for a woman. in Support of Mot. Filed: August 27, 2021. [59] at 16. for Women Alumnae Ass'n,998 So.2d 993, 998 (Miss. Care, Saint Paul, MN- 503A Facility, HHCS Pharmacy, Inc. (dba Freedom Pharmacy), Orlando, FL- 503A Facility, Hieber's Pharmacy, Pittsburgh, PA- 503A Facility, Hiers Enterprises, LLC, (dba Northwest Compounding Pharmacy), Roseburg, OR- 503A Facility, Highland Pharmacy (see In Your Atmosphere Holdings, LLC), Santa Fe, NM- 503A Facility, Home Care Pharmacy of Palm Coast Inc., Palm Coast FL- 503A Facility, HomeChoice Partners, Inc., (dba Bioscrip Infusion Services), Augusta, GA- 503A Facility, Home Infusions Solutions, Inc., Horsham, PA- 503A Facility, Home Intensive Care Pharmacy, Inc., San Antonio, TX- 503A Facility, HomeRx, LLC, (see WellRx, LLC), Wheaton, IL- 503A Facility, Hopewell Pharmacy and Compounding Center,(see Drugs Are Us, Inc.), Hopewell, NJ- 503A Facility, Hopkinton Drug, Inc., Hopkinton, MA- 503A Facility, Horizon Pharmaceuticals, Inc., Riviera Beach, FL- 503A Facility, Hospira Inc., A Pfizer Company, McPherson, KS- 503A Facility, HRI Pharmacy,(see National Prescription Services), Warrenville, IL- 503A Facility, Humco Holding Group, Inc., Texarkana, TX- 503A Facility, Hunter Holmes McGuire Veterans Admin Medical Center, Richmond, VA- 503A Facility, HV Pharmacy Inc. (dba Hunt Valley PharmaLab), Cockeysville, MD- 503A Facility, Hybrid Pharma LLC, Deerfield Beach, FL- 503B Facility, Ideal Specialty Apothecary Inc., (dba Ideal Pharmacy), Union, NJ - 503A Facility, ImClone Systems, LLC, Branchburg, NJ - 503A Facility, ImprimisRx, LLC, Carlsbad CA- Corporate Headquarters, ImprimisRx CA Inc. (dba ImprimisRx), Irvine CA- 503A Facility - Out of business, Imprimis NJOF, LLC, Ledgewood, NJ- 503B Facility, ImprimisRx NJ, Ledgewood, NJ- 503A Facility, ImprimisRx Pharmacy, LLC, Folcroft, PA- 503A Facility - Out of business, INCELL Corporation, LLC, San Antonio, TX- 503A Facility - De-registered as an Outsourcing Facility, Infupharma, LLC(dba President Pharmacy), Hollywood, FL- 503A Facility, InfuScience Inc., Eagan, MN- 503A Facility, InfuScience a subsidiary of Bioscrip, Mount Pleasant, SC- 503A Facility, InfuScience, Inc., (dba Bioscrip Infusion Services), Chantilly, VA- 503A Facility, Infusion Options, Inc., Brooklyn, NY- 503A Facility - Out of business, Infusion Partners, LLC, Canfield, OH- 503A Facility, Infusion Partners (subsidiary of BioScrip), Sharpsburg, PA- 503A Facility, Infusion System of SW Florida Inc. (dba Myerlee Pharmacy), Fort Myers, FL- 503A Facility, Infusion Treatment Center, dba ITC Compounding, Castle Rock, CO- 503A Facility, Innovative Compounding Pharmacy, Folsom, CA- 503A Facility, Innovation Compounding, Inc. Kennesaw, GA- 503A Facility, Innovative Intrathecal Solutions, Inc. (dba Innovative Compounding Pharmacy), Murrieta, CA- 503A Facility, Innovative Medicine LLC, Long Island City, NY- 503A Facility, Innoveix Pharmaceuticals, Addison, TX- 503A Facility, Insight Pharmacy, Havertown, PA- 503A Facility, Intact Pharmaceuticals, LLC, New Milford, CT- 503B Facility - Out of business, IntegraDose Compounding Services, LLC, Minneapolis, MN- 503B Facility, Integrated Health Concepts Inc. (dba Conversio Health), San Luis Obispo, CA- 503A Facility, Intermountain Medical Center, Murray, UT- 503A Facility, Intrathecal Compounding Specialist, LLC, Scott, LA- 503A Facility, Inventive Infusion Solutions, LP, San Antonio, TX- 503A Facility, In Your Atmosphere Holdings LLC (dba Highland Pharmacy) Santa Fe, NM- 503A Facility, Ionia Pharmacy, Tustin, CA- 503A Facility, Irmat Pharmacy (see Park Irmat Corp.) New York, NY- 503A Facility, Isomeric Pharmacy Solutions, LLC, Salt Lake City, UT- 503A Facility - Out of business, Isorx, Corp., Richmond, CA- 503A Facility, IV Solutions of Lubbock(see Maxor National Pharmacy Services Corporation), Lubbock, TX- 503A Facility, I.V. (Ward, S) (Entered: 07/06/2021), DocketMinute Entry for proceedings before District Judge Denise Page Hood: Motion Hearing held on 6/23/2021 re #18 MOTION to Dismiss Plaintiff's Amended Complaint filed by Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions Disposition: Motion taken under advisement (Court Reporter: Sheri Ward) (LSau) (Entered: 06/24/2021), Docket(#24) REPLY to Response re #18 MOTION to Dismiss Plaintiff's Amended Complaint filed by Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions. AIS argues that BCBS and AHS identified no provision in the Agreement that requires it to personally fill/refill the pumps or provide ongoing services. If no request is filed, the transcript may be made remotely electronically available to the public without redaction after 90 days. Infusion Solutions allows patients to utilize our state-of-the-art Private Infusion Suites for all their intravenous (IV) therapy needs. Get billing and insurance guidance At AIS Healthcare, we want to make the billing and reimbursement process as easy as possible for you. [62] 88-144. Advanced Infusion Solutions is a provider established in Ridgeland, Mississippi operating as a Pharmacy with a focus in home infusion therapy pharmacy . The covenant of good faith and fair dealing is implied in every contract. Supplemental Electronic ROA due on 11/08/2021. Docket for Advanced Reimbursement Solutions LLC v. Aetna Life Insurance Company, 2:19-cv-05395 Brought to you by the RECAP Initiative and Free Law Project, a non-profit dedicated to creating high quality open legal information. Id. 2:21-CV-12966 | 2021-12-20. A federal district judge in Baltimore, Md., yesterday stayed the brand drug industry's lawsuit challenging the December 2020 340B program administrative dispute resolution final rule. The elements of fraud and intentional misrepresentation are identical, and therefore Rule 9(b)'s heightened pleading standard applies to the latter claim. [9659120-2] Initial AA Check Due satisfied. A subscription to PACER is required. For the reasons stated, the Court DENIES AIS's Motion to Dismiss Counterclaim [56]. Id. Id. for a lawsuit in American courts[. United States ex rel. The plausibility standard does not ask for a probability of unlawful conduct but does require more than a "sheer possibility." Lawyers for Pharmaceutical Research and Manufacturers of America and U.S. Health and Human Services Secretary Xavier Becerra on Friday jointly asked U.S . See Order [61]. And by breaching the Agreement, AIS caused BCBS to wrongfully pay the S9328 code. Advanced Infusion Solutions. Advanced Infusion Care Clinton 132 Fairmont Street, Suite B Clinton, MS 39056 P: 601.988.1710 I 888.339.2144 F: 229.242.9914 I 844.259.0209 URAC accredited for Specialty Pharmacy Advanced Infusion Care Valdosta 212 Northside Drive Valdosta, GA 31602 P: 229.242.3060 | 800.482.8466 F: 229.242.9914 URAC accredited for Specialty Pharmacy Human Drug Compounding, Recalls, Market Withdrawals and Safety Alerts, Compounding Quality Center of Excellence On-demand Training, Compounding Oversight and Compliance Actions, Compounding: Inspections, Recalls, and other Actions, Consumer and Health Care Professional Information, Guidance, Compliance, & Regulatory Information, 2014 - 2015 Compounding: Inspections, Recalls, and other Actions, Referral Letter to the California State Board of Pharmacy Issued 07/06/2020, Referral Letter to the Florida State Board of Pharmacy Issued 02/15/2017, Referral Letter to the Virginia State Board of Pharmacy dated 01/29/2020, Referral Letter to the Missouri Board of Pharmacy dated 06/16/2022, Referral Letter to the Nevada State Board of Pharmacy dated 07/13/2022, Referral Letter to the Virginia State Board of Pharmacy Issued 06/08/2017, Referral Letter to the New York State Board of Pharmacy Issued 05/08/2017, Referral Letter to the Delaware State Board of Pharmacy Issued 04/28/2017, Referral Letter to Florida State Board of Pharmacy Issued 10/09/2015, Referral Letter to the New York State Board of Pharmacy Issued 03/22/2017, Referral Letter to Florida Board of Pharmacy Issued 02/21/2014, Referral Letter to State of New Hampshire Board of Pharmacy Issued 06/07/2016, Referral Letter to the Kansas State Board of Pharmacy Issued 03/06/2019, Referral Letter to the North Carolina State Board of Pharmacy Issued 08/19/2019, Referral Letter to the Arizona State Board of Pharmacy Issued 04/09/2020, Referral to the Rhode Island State Board of Pharmacy Issued 07/25/2017, Referral Letter to the California State Board of Pharmacy Issued 08/31/2017, Referral to the New York State Board of Pharmacy Issued 11/16/2017, Referral Letter to the Mississippi Board of Pharmacy Issued 08/02/2016, Referral Letter to the Ohio State Board of Pharmacy Issued 10/29/2019, Referral Letter to the Ohio State Board of Pharmacy Issued 05/01/2019, Referral Letter to the Florida Board of Pharmacy Issued on 01/31/17, Referral Letter to the Georgia State Board of Pharmacy Issued 11/18/2019, Referral to the Connecticut State Board of Pharmacy Issued 07/12/2017, Referral Letter to the Louisiana Board of Pharmacy Issued 11/03/2022, Referral Letter to the Michigan Board of Pharmacy Issued 03/22/2017, Referral Letter to the Ohio State Board of Pharmacy Issued 08/09/17, Referral Letter to the Pennsylvania State Board of Pharmacy Issued 01/17/17, Referral Letter to the California State Board of Pharmacy Issued 07/20/2020, FDA Alerts Health Care Professionals and Patients not to Use Sterile Drug Products from Chen Shwezin Inc., dba Park Compounding Pharmacy, Referral Letter to the Michigan Board of Pharmacy Issued 09/09/16, Referral Letter to the Ohio Board of Pharmacy Issued 05/30/2014, Referral Letter to the Mississippi State Board of Pharmacy Issued 11/05/2019 Shutdown Letter, Referral Letter to the Mississippi Board of Pharmacy Issued 06/27/2019, Referral Letter to the Georgia State Board of Pharmacy Issued 02/15/2017, Referral Letter to the Indiana State Board of Pharmacy Issued 10/02/2019, Referral Letter to the Arkansas State Board of Pharmacy Issued 10/28/2020, Referral Letter to the California State Board of Pharmacy Issued 12/14/2015, Leader of $17 Million Health Insurance Fraud Scheme Ordered to Prison, Referral Letter to the Texas State Board of Pharmacy Issued 05/18/2020, FDA Requested Recall Letter Issued 09/09/2014, FDA Requested Recall Letter Issued 07/26/2013, Referral Letter to New Jersey State Board of Pharmacy Issued 02/21/2014, Referral Letter to the Georgia State Board of Pharmacy Issued 05/19/2020, Referral Letter to the Minnesota State Board of Pharmacy Issued 04/29/2019, FDA warns patients and health care professionals not to use sterile products from North American Custom Laboratories LLC, dba FarmaKeio Superior Custom Compounding, Referral Letter to Missouri Board of Pharmacy Issued 02/26/2014, Referral Letter to the Alaska State Board of Pharmacy dated 02/18/2020, Referral Letter to the Alaska State Board of Pharmacy dated 02/06/2020, Referral Letter to the Tennessee Board of Pharmacy Issued 02/08/2017, FDAs Investigation into Guardians Compounded Triamcinolone-Moxifloxacin Drug Product, FDA Alerts Health Care Professionals of Adverse Events Associated with Guardians Compounded Triamcinolone and Moxifloxacin Product for Intravitreal Injection, Corrected (No Redactions) 483 Issued 10/21/2016, Referral Letter to the Texas State Board of Pharmacy Issued 03/24/2021, Referral to the California State Board of Pharmacy Issued 09/26/2017, Referral Letter to the Michigan State Department of Licensing and Regulatory Affairs (LARA) Issued 05/21/2015, Referral Letter to the Florida State Board of Pharmacy Issued 01/23/2017, Referral Letter to the Pennsylvania State Board of Pharmacy Issued 03/27/2014, Referral Letter to the Texas State Board of Pharmacy Issued 05/05/2016, Referral Letter to the Maryland State Board of Pharmacy Issued 08/23/2019, A Case of Hemorrhagic Occlusive Retinal Vasculitis (HORV) Following Intraocular Injections of a Compounded Triamcinolone, Moxifloxacin, and Vancomycin Formulation, FDA Investigates Two Serious Adverse Events Associated with ImprimisRxs Compounded Curcumin Emulsion Product for Injection, Investigation Memo and Attachments, 08/16/2011, Referral Letter to the Minnesota State Board of Pharmacy Issued 07/01/2019, Referral to the South Carolina State Board of Pharmacy Issued 09/13/2017, Referral Letter to the Ohio Board of Pharmacy Issued 03/28/2019, Referral Letter to the ColoradoBoard of Pharmacy Issued 12/23/2020, Referral Letter to the Pennsylvania State Board of Pharmacy Issued 10/03/2019, Referral Letter to the New Mexico State Board of Pharmacy Issued 08/22/2017, Maxor National Pharmacy Services Corporation, Referral Letter to the Texas Board of Pharmacy Issued 03/18/2014, Alexandria Medical Arts Pharmacy & Compounding Laboratory, Referral Letter to the Florida Board of Pharmacy Issued 04/21/2017, FDA announces Glades Drugs nationwide voluntary recall of Compounded Multivitamins containing High Amounts of Vitamin D3 (Cholecalciferol), Referral Letter to the California State Board of Pharmacy Issued 12/06/2019, Referral Letter to the Missouri State Board of Pharmacy Issued 01/10/2017, Referral Letter to the Missouri State Board of Pharmacy Issued 03/10/2016, Referral Letter to the Ohio State Board of Pharmacy Issued 08/11/2015, Referral Letter to the Illinois State Board of Pharmacy Issued 09/11/2019, Referral Letter to the New York State Board of Pharmacy Issued 11/15/2019, Referral Letter to the California State Board of Pharmacy Issued 11/22/2019, Referral Letter to the Nebraska State Board of Pharmacy Issued 07/11/2019, Referral Letter to Oklahoma State Board of Pharmacy Issued 02/25/2014, Referral Letter to the New York State Board of Pharmacy Issued 06/06/2019, Referral Letter to the Massachusetts Department of Public Health Issued 10/14/2015, Referral to the New York State Education Department, Office of the Professions, Pharmacy Issued 07/07/2017, Referral Letter to the Minnesota State Board of Pharmacy Issued 04/10/2019, Referral Letter to the Oklahoma State Board of Pharmacy Issued 10/2/2020, Referral Letter to the Missouri Board of Pharmacy Issued 02/18/2015, FDA Requested Recall Letter Issued 05/03/2016, Referral Letter to the South Carolina State Board of Pharmacy Issued 05/21/2015, Referral to the Texas State Board of Pharmacy Issued 07/28/2017, State Referral Letter to the Nevada State Board of Pharmacy issued 12/06/2017, Referral Letter to Massachusetts Board of Registration in Pharmacy Issued 01/20/2016, Barclay Luke & Pillai Specialty Pharmacy PLLC, Referral Letter to the Arizona State Board of Pharmacy Issued 05/23/2017, Referral Letter to the Michigan State Board of Pharmacy Issued 06/13/2019, Referral Letter to the Tennessee Board of Pharmacy Issued 04/05/2017, Referral Letter to the Wisconsin State Board of Pharmacy Issued 06/13/2019, Referral Letter to the Nebraska State Board of Pharmacy Issued 05/09/2016, Unlicensed Pharmacy Technician Sentenced for Working at New England Compounding Center, Owner and Four Former Employees of New England Compounding Center Convicted Following Trial, Unlicensed Pharmacy Technician Pleads Guilty to Working at New England Compounding Center, Compounding Pharmacy Owner Sentenced to Five Years in Prison for $10.5 Million Health Care Fraud, Multistate outbreak of fungal meningitis and other infections, Referral to the Massachusetts State Board of Registration in Pharmacy Issued 09/26/2017, Referral Letter to New Hampshire State Board of Pharmacy Issued 04/29/2015, Referral Letter to the Kentucky State Board of Pharmacy Issued 03/04/2020, Referral to the Kansas State Board of Pharmacy Issued 06/28/2017, Referral Letter to the Illinois State Board of Pharmacy Issued 07/01/2020, Referral Letter to the Illinois State Board of Pharmacy Issued 10/31/2019, Referral Letter to the California State Board of Pharmacy Issued 07/08/2020, Referral Letter to Florida State Board of Pharmacy Issued 03/10/2021, Amended 483 and Cover Letter Issued 04/09/2013 and 483 Issued 03/29/2013, Referral Letter to the Tennessee State Board of Pharmacy Issued 09/13/2019, Referral Letter to the Florida State Board of Pharmacy Issued 04/22/2019, Referral Letter to the Pennsylvania State Board of Pharmacy Issued 05/05/2017, Pentec Health Announces Limited Voluntary Recall of Certain Compounded Prescription Therapies for Renal Patients, Referral Letter to the Texas State Board of Pharmacy Issued 03/12/2019, Referral Letter to the Kansas State Board of Pharmacy Issued 03/29/2017, Pharmacy Creations Issues Voluntary Recall of Four Product Lots With Limited Distribution in Florida, New Jersey, New York, and Puerto Rico Due to Potential Non-Sterility (09/04/2014), Referral Letter to the Indiana State Board of Pharmacy Issued 03/06/2017, Pharmacy Owner and Director of Compliance Charged with Defrauding United States and Distributing Adulterated Drugs, Referral Letter to the New Jersey State Board of Pharmacy Issued 07/29/2019, Referral to the Oklahoma State Board of Pharmacy Issued 07/28/2017, Referral Letter to the Georgia State Board of Pharmacy Issued 08/14/2020, Referral Letter to New York State Board of Pharmacy Issued 11/07/2016, Referral Letter to the New Jersey State Board of Pharmacy Issued 01/11/2017, Referral Letter to Michigan Board of Pharmacy Issued 02/25/2014, Referral Letter to the California State Board of Pharmacy Issued 04/05/2017, Referral Letter to the Colorado State Board of Pharmacy Issued 04/14/2020, Referral Letter to the FloridaBoard of Pharmacy Issued 07/27/2022, Referral Letter to the Ohio State Board of Pharmacy Issued 09/12/2019, Referral to the New York State Board of Pharmacy Issued 06/15/2017.

Disney Black Bean Vinaigrette Recipe, Articles A